Literature DB >> 12127316

Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation.

Mildred García1, María Monge, Guillermo León, Sergio Lizano, Eduardo Segura, Gabriela Solano, Gustavo Rojas, José María Gutiérrez.   

Abstract

Intravenous administration of antivenoms is associated with early adverse reactions in a number of cases, but the causes of this phenomenon are still unclear. The effect of preservatives (phenol and thimerosal) on IgG aggregate and dimer formation, in vitro complement-activating effect and hypotensive activity of a whole IgG horse liquid polyvalent antivenom, produced by caprylic acid fractionation, was assessed. These parameters were studied since they have been associated with the development of early adverse reactions to the administration of antivenoms and human immunoglobulins. After a three-year storage period at 4 degrees C, antivenoms with preservatives had an increased content of IgG aggregates and dimers when compared with antivenom devoid of phenol and thimerosal. These observations correlate with a slight increment in the turbidity of preservative-containing antivenoms. The three antivenoms studied (formulation: no preservatives; with phenol and thimerosal; with thimerosal alone) activated human complement in vitro, with only minor quantitative differences among them. When antivenoms were administered as a bolus intravenous injection in rats, a rapid and prominent hypotension of short duration was observed after injection of phenol-containing antivenom, whereas such an effect was absent in antivenom free of preservative and in the one containing only thimerosal. Bolus injection of saline solution with phenol resulted in a similar hypotension, indicating that the effect is due to phenol. However, when phenol-containing antivenom was diluted 1:5 with saline solution before infusion, as occurs in the clinical use of this product, no hypotension was observed. Our results stress the need to evaluate the effects of preservatives on the physicochemical and pharmacological characteristics of antivenoms. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127316     DOI: 10.1006/biol.2002.0329

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  10 in total

Review 1.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

2.  Anticomplementary activity of horse IgG and F(ab')2 antivenoms.

Authors:  Carla Cristina Squaiella-Baptistão; José Roberto Marcelino; Luiz Eduardo Ribeiro da Cunha; José María Gutiérrez; Denise V Tambourgi
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Streamlined downstream process for efficient and sustainable (Fab')2 antivenom preparation.

Authors:  Tihana Kurtović; Marija Brgles; Maja Lang Balija; Stephanie Steinberger; Dora Sviben; Martina Marchetti-Deschmann; Beata Halassy
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-07-27

Review 4.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

5.  Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study.

Authors:  Choo Hock Tan; Jia Lee Liew; Kae Yi Tan; Nget Hong Tan
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

6.  Quality of horse F(ab')2 antitoxins and anti-rabies immunoglobulins: protein content and anticomplementary activity.

Authors:  Carla Cristina Squaiella-Baptistão; Fábio Carlos Magnoli; José Roberto Marcelino; Osvaldo Augusto Sant'Anna; Denise V Tambourgi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-06-18

7.  Refinement strategy for antivenom preparation of high yield and quality.

Authors:  Tihana Kurtović; Maja Lang Balija; Marija Brgles; Dora Sviben; Monika Tunjić; Hrvoje Cajner; Martina Marchetti-Deschmann; Günter Allmaier; Beata Halassy
Journal:  PLoS Negl Trop Dis       Date:  2019-06-17

Review 8.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

Review 9.  Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Authors:  Rashmi Dixit; Jenny Herz; Richard Dalton; Robert Booy
Journal:  Vaccine       Date:  2016-01-20       Impact factor: 3.641

10.  Assessment of quality and pre-clinical efficacy of a newly developed polyvalent antivenom against the medically important snakes of Sri Lanka.

Authors:  Aparup Patra; Bhargab Kalita; Milind V Khadilkar; Nitin C Salvi; Pravin V Shelke; Ashis K Mukherjee
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.